Previous Article | Next Article 
Infect Immun, June 1998, p. 2648-2654, Vol. 66, No. 6
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Borrelia burgdorferi Erp Proteins Are Immunogenic
in Mammals Infected by Tick Bite, and Their Synthesis Is
Inducible in Cultured Bacteria
Brian
Stevenson,*
James L.
Bono,
Tom G.
Schwan, and
Patricia
Rosa
Laboratory of Microbial Structure and
Function, Rocky Mountain Laboratories, National Institute of
Allergy and Infectious Diseases, National Institutes of Health,
Hamilton, Montana 59840
Received 5 December 1997/Returned for modification 13 February
1998/Accepted 24 March 1998
 |
ABSTRACT |
Borrelia burgdorferi, the causative agent of Lyme
disease, can contain multiple genes encoding different members
of the Erp lipoprotein family. Some arthropod-borne bacteria increase
the synthesis of proteins required for transmission or mammalian
infection when cultures are shifted from cool, ambient air temperature
to a warmer, blood temperature. We found that all of the
erp genes known to be encoded by infectious isolate B31
were differentially expressed in culture after a change in temperature,
with greater amounts of message being produced by bacteria shifted from
23 to 35°C than in those maintained at 23°C. Mice infected with B31 by tick bite produced antibodies that recognized each of the Erp proteins within 4 weeks of infection, suggesting that the Erp proteins
are produced by the bacteria during the early stages of mammalian
infection and may play roles in transmission from ticks to mammals.
Several of the B31 Erp proteins were also recognized by antibodies from
patients with Lyme disease and may prove to be useful antigens for
diagnostic testing or as components of a protective vaccine.
 |
INTRODUCTION |
Borrelia burgdorferi, the
causative agent of Lyme disease, is spread to humans and other mammals
through the bites of infected Ixodes ticks (8).
In unfed ticks, the bacteria are primarily restricted to the midgut,
and as ticks feed, bacteria migrate from the midgut to the salivary
glands and are transmitted into the bite wound with the saliva (5,
19, 28, 30, 50). This mode of transmission undoubtedly requires
that B. burgdorferi recognize when the host tick is
feeding on a warm-blooded animal and then synthesize proteins required
for transmission and the subsequent establishment of infection in the
mammalian host. We are seeking to identify the proteins that are
important in B. burgdorferi transmission and,
ultimately, the factors that regulate their synthesis.
Many bacteria utilize environmental temperature as a signal to
determine their location, synthesizing vector-specific proteins at the
cooler temperatures experienced within an arthropod and mammal-specific
proteins at warmer, blood temperatures (6, 20, 26, 38, 39).
Differences in temperature may also change bacterial growth rates,
which in turn may provide internal signals affecting the production of
vector- or mammal-specific proteins. We have previously reported that
B. burgdorferi increases the synthesis of certain
proteins during tick feeding or after a shift in culture temperature
from 23 to 35°C (34, 42, 45). This temperature change also
results in a marked increase in bacterial growth rate (approximately
three to four times greater in bacteria shifted from 23 to 35°C than
in those maintained at 23°C) (42), and B. burgdorferi in infected ticks also undergoes a dramatic increase
in growth rate during tick feeding (14, 28).
The B. burgdorferi proteins that we reported as being
differentially synthesized as a result of temperature shift were
recognized by sera from infected animals (34, 42),
indicating that they are normally synthesized by the bacteria during
mammalian infection. At least one of these proteins, OspC, is not
synthesized by B. burgdorferi within the midgut of
unfed ticks (16, 34), whereas bacteria within the midgut and
salivary glands of ticks that have engorged with blood produce OspC
(12, 15, 34), suggesting that this protein is involved with
bacterial transmission or the early stages of mammalian infection.
We also found that the OspE and OspF proteins of B. burgdorferi N40 (23) were differentially synthesized
after a shift in culture temperature from 23 to 35°C (42).
Analyses of B. burgdorferi B31 indicated that this
isolate can carry many members of a family of genes that are homologous
to, and apparently allelic with, the N40 ospEF locus, which
we have designated erp (OspEF-related proteins) (11,
43). We previously characterized the four erp loci
present in a noninfectious B31 culture that has been passage repeatedly
in laboratory culture medium and have found that each erp
locus is carried on one of four homologous 32-kb circular plasmids
(cp32-1 through cp32-4) (11, 43). However, infectious, low-passage-number B31 bacteria may contain at least seven 32-kb circular plasmids (cp32-1 through cp32-7), each containing an erp locus (11). Infectious B31 can also carry a
related linear plasmid (lp56) (11, 48, 49) that was not
previously known to contain an erp locus. Since this large
number of different genes and proteins could allow for a wide range of
expression patterns, characterizing all of the erp genes and
their proteins within a particular isolate is an essential step toward
understanding the roles that these proteins may play in B. burgdorferi transmission and the establishment of Lyme disease
infections. Due to the extensive sequence similarities of the cp32
plasmids, they could not be confidently assembled by the B. burgdorferi B31 genome sequencing project of The Institute for
Genomic Research (17), and their complete sequences have not
yet been published. Homologs of the B31 Erp proteins have been
identified in other isolates of B. burgdorferi,
although no more than three loci have been described from any isolate
other than B31 (1, 23, 25, 44, 46). Immune responses
directed against Erp homologs have also been described, but again,
these analyses are incomplete, as only one or two proteins from any
isolate have been examined (13, 27, 46). In this report we
describe all of the erp genes known to be carried by an
infectious culture of B31 and show that all of the erp genes
tested can be expressed by cultured bacteria by changing the
temperature from 23 to 35°C. We also found that tick-infected laboratory animals produced antibodies that recognized all of the known
B31 Erp proteins, as did many human Lyme disease patients.
 |
MATERIALS AND METHODS |
Bacteria.
B. burgdorferi B31 was originally
isolated from an infected Ixodes scapularis tick collected
on Shelter Island, New York (8). These bacteria have been
maintained in the laboratory via an infectious cycle between I. scapularis ticks and mice (34). Clone B31-4a was
derived from a single colony of infectious B31 plated on solid Barbour-Stoener-Kelly (BSK) medium (22, 31) and is also
infectious in laboratory mice (11).
All B. burgdorferi isolates were cultured in BSK-H
broth (Sigma, St. Louis, Mo.) supplemented with 6% rabbit serum
(Sigma). Cultures used to determine temperature shift differential
synthesis of B. burgdorferi proteins, and mRNAs were
grown at 23 or 35°C as previously described (34, 42).
Briefly, 100-ml cultures were grown at 23°C until the culture
reached a density of approximately 107 bacteria per ml
(approximately 3 weeks); 1 ml of this culture was diluted into 100 ml
of fresh medium and grown at 35°C to a similar density (approximately
4 to 6 days). Both cultures were harvested by centrifugation.
Cloning and sequence analysis of erp genes.
Plasmid DNAs from B31-4a were purified with a Qiagen (Chatsworth,
Calif.) midi-purification kit from a 100-ml culture grown at 35°C.
The erpAB2 and erpX loci were PCR amplified by
using oligonucleotides specific to the orf3 gene found on
cp32-1 and lp56, respectively (11, 40, 49) and a conserved
DNA sequence that is located approximately 1.5 kb 3' of every
erp locus (2, 11, 41) (Table
1). For PCR performed with an Expand Long Template PCR kit (Boehringer Mannheim, Indianapolis, Ind.), reaction conditions consisted of 94°C for 30 s, 50°C for 30 s, and
68°C for 8 min, followed by 20 cycles of the same conditions but with successive elongation steps increasing by 20 s each cycle
(41).
The complete sequences of the B31-4a
erpIJ and
erpLM loci were determined from previously described DNA
fragments (
11).
The
erpAB2 and
erpIJ
loci were sequenced from uncloned PCR fragments.
The
erpLM
and
erpX loci were each sequenced from two separate
PCR
amplification products that had been cloned into the TA vector
pCR2.1
(Invitrogen, San Diego, Calif.). All DNA sequencing was
performed with
a model 370A Stretch automated DNA sequencer (Applied
Biosystems,
Foster City, Calif.).
Analysis of mRNA.
Total RNA was extracted from B. burgdorferi B31-4a grown at 23°C or shifted to 35°C, using an
Ultraspec RNA isolation system (Biotecx, Houston, Tex.) according to
the manufacturer's instructions. The RNA was denatured with glyoxal
and dimethyl sulfoxide, separated by agarose gel electrophoresis in 10 mM sodium phosphate buffer (pH 7.0) (32), and transferred to
nylon membranes (Micron Separations, Westborough, Mass.). Probes
specific for the B31 erp, bapA, and flaB (flagellin) genes were generated by PCR from
recombinant plasmids carrying the appropriate loci, using the
oligonucleotides listed in Table 1, as previously described
(43). DNA fragments were radiolabeled with
[
-32P]dATP (Du Pont, Boston, Mass.) by random priming
(Life Technologies, Gaithersburg, Md.). Filters were hybridized with
each radiolabeled probe at 55°C in 1% (wt/vol) bovine serum
albumin-7% (wt/vol) sodium dodecyl sulfate (SDS)-0.5 M sodium
phosphate (pH 7.0)-1 mM EDTA and washed at 55°C in 0.2× SSC (1×
SSC is 0.15 M NaCl and 0.015 M sodium citrate)-0.1% (wt/vol) SDS as
previously described (7).
Protein purification and analysis.
B. burgdorferi
cultures were pelleted by centrifugation, washed twice with
phosphate-buffered saline, resuspended in sample buffer
(32), and lysed by boiling for 5 min.
DNA fragments encoding
erpA,
erpB2,
erpC,
erpD,
erpG,
erpK,
erpL,
erpM, and
erpX were individually
cloned into pProEX-1 (Life
Technologies), so that each gene was in the
correct reading frame
to encode a fusion protein with the
plasmid-encoded polyhistidine
polypeptide. Recombinant plasmids were
transformed into
Escherichia coli DH5

(Life
Technologies). A single colony from each transformation
was grown at
37°C to early log phase in 100 ml of LB broth (
24),
induced with 100 µg of isopropyl thiogalactoside per ml, and grown
for an additional 2 h before harvesting by centrifugation. The
bacteria were lysed by sonication, and the fusion proteins were
purified by using His-Bind Resin column chromatography kits (Novagen,
Madison, Wis.) as recommended by the manufacturer.
Proteins were separated by SDS-polyacrylamide gel electrophoresis
(
21) and visualized by staining with Coomassie brilliant
blue. Alternatively, proteins were transferred to nitrocellulose
membranes (Life Technologies) and immunoblotted as previously
described
(
45), using horseradish peroxidase-linked protein
A
(Amersham, Arlington Heights, Ill.) and SuperSignal chemiluminescent
substrate (Pierce, Rockford, Ill.).
Antisera.
Uninfected larval I. scapularis ticks,
hatched and reared at our facility, were fed on white-footed mice
(Peromyscus leucopus) that had previously been infected with
B. burgdorferi B31. After molting to the nymphal stage,
ticks were placed on uninfected white-footed mice and allowed to feed
to repletion. Approximately 15 to 25 ticks were fed on each mouse. Sera
were collected 4 weeks (two mice) or 8 weeks (three mice) after tick
attachment. Infection was determined by immunoreactivity to the
B. burgdorferi BmpA (P39) protein, an antigen
diagnostic of active infection (35, 37). Sera were also
collected from two mice that were not infected with B. burgdorferi.
Sera from three of the mice infected for 8 weeks were pooled and
preadsorbed with individual recombinant B31 Erp proteins
to remove
specific antibodies in subsequent immunoblot studies.
Sera were diluted
1:500 in TBS (Tris-buffered saline)-Tween (20
mM Tris [pH 7.5], 150 mM NaCl, 0.05% [vol/vol] Tween 20) (
45)
and incubated at
37°C for 2 h with approximately 10 µg of each
recombinant B31
Erp protein.
Sera from 10 Lyme disease patients with unknown stages of infection
from Southampton, Long Island, N.Y. (
37), were used
in
immunoblotting assays to determine reactivity to recombinant
B31 Erp
proteins. Additionally, sera from five noninfected humans
from Montana
(where Lyme disease is not endemic) were also used
in these
immunoblotting experiments. All human sera were diluted
1:200 in
TBS-Tween for immunoblotting.
Nucleotide sequence accession numbers.
The complete
sequences of the B31 erpAB2, erpIJ,
erpLM, and erpX loci have been deposited in
GenBank and given accession no. U78764, U72996, U72998, and AF020657,
respectively. The previously described B31 erpAB1,
erpCD, erpG, erpH, and erpK loci have the GenBank accession no. U44912, U44914, U42598, U44913, and
U72997, respectively (11, 43).
 |
RESULTS |
erp gene complement of an infectious B. burgdorferi B31 culture.
To aid in our elucidation of Erp
protein expression and function, we cloned and sequenced the
erp loci carried on the known cp32 plasmid family members in
an infectious culture of isolate B31. The infectious B. burgdorferi clone B31-4a carries lp56 and all of the known cp32
plasmids except cp32-2 (11). The B31 Erp proteins were found
to vary significantly in sequence, with aligned pairs sharing between
100 and 17% amino acid residues (40). Since all of these
plasmids are homologous throughout most of their lengths (11, 29,
41, 43, 49), we believe that all members of the erp
gene family are actually alleles of one another. However, for the sake
of clarity in discussing each gene and its protein, we have chosen to
retain the designations of these genes as erpA,
erpB, etc. (Table 2).
The
erpB gene (located on cp32-1) of the infectious
B. burgdorferi B31 is slightly different from the gene
that we found in
a high-passage-number noninfectious culture of
B. burgdorferi B31 (
43). We have designated
the low-passage-number form of
erpB as
erpB2 and
the high-passage-number form as
erpB1. These
two genes are
identical except for the sequence at codon 219,
which is TAG (stop) in
erpB1 and GAG (glutamic acid) in
erpB2.
As a
result,
erpB2 encodes a longer, 378-amino-acid protein with
a predicted molecular mass of 43.6 kDa. The
erpA genes of
both
the low- and high-passage-number B31 bacteria were found to be
identical in sequence.
The majority of bacteria in our infectious B31 culture lack cp32-2 and
the
erpCD locus (
11), and we have not been able
to
isolate an infectious clone of B31 that contains this plasmid.
We
were therefore unable to characterize the expression of the
erpCD locus during this work. The bacteria in this culture
do
carry cp32-3 and cp32-4 (
11), which contain
erpG and
erpH, respectively
(
43). The
erpG gene is followed by
bapA (
43,
46), which
is not homologous to the
erp genes and is
not a member of this
gene family.
erpH encodes a small
protein that, if processed by
cleavage of the signal polypeptide, would
be only 15 amino acids
in length (
11,
43). Since such a
protein would probably be
nonfunctional, we have not characterized the
expression of
erpH in this work.
Plasmid cp32-5 contains a bicistronic locus,
erpIJ, the
coding regions of which are identical to those of
erpAB2. We
are confident
that these genes comprise two separate loci since the 5'
noncoding
regions of
erpAB and
erpIJ are distinct
(
11). Additionally,
we have linked the
erpAB and
erpIJ loci to the distinct
orfC and
orf3 alleles that are found only on cp32-1 and cp32-5,
respectively
(
11,
40,
49). Finally, a probe derived from
erpB hybridized
to restriction endonuclease fragments
originating from both cp32-1
and cp32-5 in our previous mapping
experiments (
11). Since we
cannot differentiate between ErpA
and ErpI or between ErpB2 and
ErpJ mRNAs or proteins, we will refer to
them collectively as
ErpA/I and ErpB2/J.
Plasmid cp32-6 contains the
erpK gene, apparently a
monocistronic locus with no indication of another open reading frame
located
within 200 bp 3' of
erpK.
Plasmid cp32-7 contains a bicistronic locus,
erpLM. The
initial 452 nucleotides of the
erpL gene are identical to
those of
the
bbk2.11 locus of
B. burgdorferi
isolate 297 (
1), resulting
in identical predicted amino acid
sequences for over half the
length of these two proteins
(
40). The remainder of the two
proteins are predicted to
share only 43% identical amino acids
(
40). Previous partial
sequencing of the 5' end of
erpL and
its similarity with the
monocistronic 297
bbk2.11 locus led us
to erroneously
predict earlier that
erpL is also monocistronic
(
11).
Linear plasmid lp56 contains
erpX, which appears to be
monocistronic since there are no identifiable
erp-related
genes located
3' of this gene. Furthermore, the DNA located immediately
3' of
erpX is almost identical to the sequences located
directly 3'
of
erpAB2,
erpCD, and
erpLM.
Transcriptional regulation of the erp genes.
The
regions of DNA located immediately 5' of all the B31 erp
loci, which presumably include the promoters and any cis
regulatory sequences, are nearly identical to that found 5' of the N40
ospEF locus (11, 23, 41, 43), suggesting that all
of these loci may be regulated similarly. The N40 OspE and OspF
proteins can be differentially synthesized in culture by shifting the
growth temperature from 23 to 35°C, as can a B31 protein that is
antigenically similar to the N40 OspE protein (42). We
therefore examined the expression of the B31-4a erp loci to
determine whether they are also similarly regulated in culture.
Northern blot analyses with probes specific for each
erp
gene indicated that significantly greater levels of the
erp
transcripts
were present in bacteria that were shifted to 35°C
relative to
those maintained at 23°C (Fig.
1A). We also examined the
expression
of the
bapA gene located 3' of
erpG on
cp32-3 and found that it,
too, was expressed at higher levels in the
bacteria shifted to
35°C (Fig.
1A).
Rehybridizations of the same RNA blots with a
probe specific for
the constitutively expressed
flaB (flagellin)
gene
(
7) indicated that there were comparable amounts of RNA
in
all samples (Fig.
1B). The slight variation seen on some
flaB-probed
filters is insufficient to account for the
differences seen when
the same filter was hybridized with
erp-specific probes (compare
Fig.
1A with Fig.
1B).
These results lead us to predict that similar
expression patterns
will be observed for other homologous loci,
such as the B31
erpCD and the
erp homologs found in other
B. burgdorferi isolates.

View larger version (39K):
[in this window]
[in a new window]
|
FIG. 1.
(A) Northern blot analysis of erp
transcripts. Isolate B31 was grown in culture medium at either a
constant temperature of 23°C (labeled 23°C) or shifted from 23°C
to 35°C (labeled 35°C). Filters were individually incubated with
radiolabeled probes specific for the B31 gene indicated above each
panel. (B) Each filter was rehybridized with a probe specific for the
constitutively expressed flaB gene (7). RNA
molecular size markers (in kilobases) are indicated to the left of each
panel.
|
|
The Northern blotting experiments also provided data indicating that
the bicistronic
erp loci constitute operons. The
erpA/I and
erpB2/J probes each hybridized to an
approximately 2-kb mRNA
transcript (Fig.
1), which is large enough to
include both genes
(1,685 bp required). Similar results were seen in
assays using
the
erpL and
erpM probes (the
erpLM coding sequences are 1,832
bp in length). Both the
erpB2/
J and
erpM probes also
hybridized
with RNAs having approximate sizes of 1.4 kb that did not
hybridize
with the
erpA/I and
erpL probes,
respectively (Fig.
1), suggesting
that these bicistronic operons may
contain internal promoters
for transcription of the second genes.
Alternatively, the smaller
transcripts may be due to degradation of the
5' ends of these
transcripts.
The
erpG and
bapA probes each hybridized to a
transcript of approximately 1.8-kb, a size sufficient to encode both
proteins
(1,211 bp required), suggesting that these two genes also
constitute
a bicistronic operon. The
erpK probe hybridized
with an mRNA having
an approximate size of 1 kb, a size sufficient to
encode the ErpK
protein (756 bp required). The
erpX probe
hybridized with a transcript
of sufficient size to encode its protein
(approximately 1.4 kb;
1,037 bp required).
Recognition of Erp proteins by animals infected with B31.
Proteins produced by B. burgdorferi during transmission
from tick to mammal might be antigenic and provoke an early immune response. Such is the case with the B. burgdorferi OspC
protein (18). Since the ospC gene exhibits an in
vitro pattern of temperature-inducible expression similar to that of
the erp genes (34, 45), we examined whether
laboratory animals infected by tick bite with isolate B31 also produced
antibodies that recognized the Erp proteins.
Recombinant Erp proteins were purified, separated by SDS-polyacrylamide
gel electrophoresis, and transferred to nitrocellulose
membranes. All
of the recombinant Erp proteins migrated with apparent
molecular masses
that were greater than those predicted from their
gene sequences (Table
2). The filters were then immunoblotted
with sera from each of five
mice that had been infected with B31
by tick bite. We observed that
every mouse produced antibodies
that reacted with all of the
recombinant Erp proteins, except
ErpD, within 4 weeks of tick feeding
(example shown in Fig.
2).
Immunoblot signals were stronger from the
ErpA/I and ErpB2/J recombinant
proteins (Fig.
2), suggesting that B31
may produce more of these
two proteins than the other Erp proteins. As
noted above, very
few of the bacteria in the infectious B31 culture
contain cp32-2
(which encodes ErpD), and the lack of ErpD-specific
antibodies
correlates with this observation. Sera from uninfected mice
did
not contain antibodies that recognized any Erp protein (data not
shown). These data are consistent with production of the Erp proteins
by
B. burgdorferi during early stages of mammalian
infection.
We cannot at this time rule out antibody cross-reactivity in the
preceding experiment. For example, most of the bacteria in
the
infectious B31 culture also lack the
erpC gene (encoded on
cp32-2), yet sera from infected mice recognized the recombinant
ErpC
protein (Fig.
2), probably due to
cross-reactive antibodies
elicited by ErpA/I. These two proteins share
extensive sequence
identity (>83% identical amino acids)
(
43), and antibodies that
recognize one protein may
recognize the other, since antibodies
raised against a recombinant N40
OspE protein (
27) recognized
both the recombinant ErpA/I and
ErpC proteins (data not shown).

View larger version (75K):
[in this window]
[in a new window]
|
FIG. 2.
Immunoblot analysis of recombinant B31 Erp proteins. The
filter was incubated with a 1:200 dilution of serum from a mouse
infected with B31 by tick bite. The immunoblot signal strengths were
greater from the recombinant ErpA/I and ErpB2/J proteins than from the
other proteins, and the exposure time of ErpA/I and ErpB2/J in this
figure was approximately 1/10 of that of the other Erp proteins. All of
the recombinant Erp proteins migrated with apparent molecular masses
that were greater than predicted from their sequences (Table 2). Some
of the recombinant protein preparations contained probable degradation
products or multimeric proteins, resulting in the presence of multiple
bands. Molecular masses (in kilodaltons) are indicated to the left.
|
|
Differential synthesis of Erp antigens.
We have previously
reported that raising the culture temperature from 23 to 35°C
resulted in the increased production of several antigenic B31 proteins
(42). Knowing that expression of the erp genes
can be temperature induced and that their proteins are antigenic, we
performed experiments to determine whether any of the previously
detected temperature-induced B31 antigens were Erp proteins. Due to the
limited amount of serum available from a single mouse, sera from three
of the infected mice described above were pooled for use in these
experiments. The pooled sera were preadsorbed with each recombinant Erp
protein and used in immunoblot analyses with a B31 lysate that had been
grown at 23°C and shifted to 35°C. The absence of a signal with an
Erp preadsorbed serum would indicate that a particular immunoblot band
corresponded with that Erp protein.
These experiments indicated that at least two of the major B31 antigens
detectable on immunoblots are Erp proteins.
Preadsorption
of the sera with recombinant ErpA/I
protein inhibited binding
to a protein with an approximate
molecular mass of 19 kDa (Fig.
3),
indicating that this differentially expressed antigen was
ErpA/I.
Binding to ErpA/I was not blocked by preincubation with
recombinant ErpC, which shares 83% identical amino acids with
ErpA/I (
43), indicating that the infected animals also
produced
antibodies against epitopes unique to ErpA/I.
Preadsorption with
recombinant ErpB2/J blocked antibody
binding to an approximately
60-kDa differentially expressed protein,
indicating that this
antigen is ErpB2/J. The ErpB2/J protein is
predicted to have a
molecular mass of 43.6 kDa but, as
noted above, the recombinant
ErpB2/J protein also migrated with a
larger apparent molecular
mass in polyacrylamide gel electrophoresis
(Fig.
2).

View larger version (44K):
[in this window]
[in a new window]
|
FIG. 3.
Identification of differentially synthesized B31
antigens. (A) Immunoblot of B31 lysates grown at a constant 23°C or
shifted from 23 to 35°C. The filter was incubated with a 1:500
dilution of serum from a mouse that was infected with B31 by tick bite.
(B) Immunoblots of a B31 lysate shifted from 23 to 35°C. A 1:500
dilution of pooled sera from three mice infected with B31 by tick bite
was preadsorbed with each recombinant B31 Erp protein before incubation
with the filter strip. Asterisks indicate the positions of bands that
were absent or diminished on immunoblots prepared with sera preadsorbed
with recombinant ErpA/I, ErpB2/J, or ErpK. Molecular masses (in
kilodaltons) are indicated to the left of each panel.
|
|
Even though the sera used in these experiments contained antibodies
that recognized the remaining Erp proteins (see above),
no other
recombinant Erp protein completely blocked antibody binding
to a
protein in the
B. burgdorferi lysate. Binding to a
protein
with an approximate molecular mass of 40 kDa was reduced by
preadsorption
with recombinant ErpK (Fig.
3). All of the
erp
genes examined
were expressed by the bacteria that were shifted
to 35°C (Fig.
1), but we cannot determine from these
experiments whether they
were also translated. The failure to detect
antibody blocking
may be due to the large number of antigens that
migrated with
apparent molecular masses of 35 to 50 kDa (Fig.
3), and
the absence
of a single band in this area might be obscured by other
comigrating
proteins. Alternatively, since the sera apparently
contained greater
levels of ErpA/I- and ErpB2/J-directed antibodies
(see above),
other Erp protein bands may be fainter and difficult to
discern.
It is also possible that there were conformational differences
between the recombinant and native Erp proteins such that antibodies
did not recognize the recombinant forms, or that the sera were
not
preincubated with enough antigen to absorb all the antibodies
directed
against that protein.
Recognition of B31 Erp proteins by human Lyme disease patient
sera.
We next analyzed sera from 10 humans with Lyme disease to
determine whether they produced antibodies that recognized the B31 Erp
proteins. All 10 patients contained antibodies that recognized the
B. burgdorferi BmpA (P39) protein, a characteristic
marker of B. burgdorferi infection (35, 37)
(data not shown). All of the sera contained antibodies that bound both
ErpA/I and ErpC (Table 3). Eight of the
patients contained antibodies that recognized ErpB2, seven recognized
ErpM, and six recognized ErpL. The remaining Erp proteins were bound by
antibodies found in half or fewer of the patients. Sera from humans
without Lyme disease and residing in an area where Lyme disease is not
endemic lacked antibodies that recognized any of the recombinant B31
Erp proteins (data not shown). These data suggest that production of
antigens similar to ErpA/I and ErpC may be common in Lyme disease
spirochetes, while fewer bacteria produce antigens similar to the other
B31 Erp proteins.
View this table:
[in this window]
[in a new window]
|
TABLE 3.
Reactivities of human Lyme disease patient antisera
(all diluted 1:200) against recombinant B31 Erp proteins
|
|
 |
DISCUSSION |
We have found that B. burgdorferi B31 contains a
large repertoire of erp genes and proteins. Expression from
the B31 erp loci tested increased in response to a culture
temperature shift that mimicked the environmental change within the
feeding tick. Additionally, animals infected by tick bite produced
antibodies that recognized the Erp proteins encoded by infectious B31.
These data are consistent with production of the Erp proteins during
the transmission of B. burgdorferi from ticks to
mammals and suggest that they may play roles in transmission or the
establishment of mammalian infection. Further studies will determine
the pattern of Erp protein synthesis within unfed and fed ticks and in
infected mammals.
It has been proposed that each of the numerous erp genes may
be expressed at different times during mammalian infection (13, 25, 43), perhaps as a method of avoiding immune clearance similar
to the presumed function of Vmp protein variation in the relapsing
fever agent, Borrelia hermsii (4). Our data
suggest that all of the B31 Erp proteins examined are synthesized at
approximately the same time during infection, as they were recognized
by antisera from tick-infected mice within the first 4 weeks of
infection. It may be argued that only a subset of the erp
genes were expressed during the infection times studied, and we
actually detected antibodies that cross-reacted with the other Erp
proteins. Yet such cross-reactivity could negate any value in
sequentially producing the Erp proteins, since protective antibodies
that recognize the later-appearing proteins might already be present.
The identity of the B31 erpAB2 and erpIJ genes
also argues against the theory of sequential expression of the
erp loci. Additionally, the conserved 5' noncoding regions of these regulons (1, 11, 23, 25, 41, 43, 44, 46) indicate
that the same regulatory factors probably interact with all of their
promoters, suggesting that expression of these loci would not be
individually controlled.
The in vitro expression of the B31 erp genes that we have
observed stands in contrast with reports that Erp homologs of other B. burgdorferi isolates were not expressed in cultured
bacteria (1, 13, 44, 46). The promoter regions of all
reported erp homologs are nearly identical, which, as noted
above, indicates that they are all probably regulated by the same
cis and trans factors. The apparently
contradictory in vitro expression patterns may be a consequence of the
culture conditions used in different experiments, since the other
reports studied protein synthesis in bacteria grown continuously at
35°C but not in cultures shifted from 23 to 35°C. It is important,
however, that regulated expression of the B. burgdorferi
erp genes can be observed in the laboratory, as the bacterial
factors responsible might now be detected and studied in detail.
Not all of the Erp proteins are essential for mammalian infection, as
bacteria lacking cp32-2 (which encodes ErpC and ErpD) are apparently
infectious and transmitted between ticks and mammals. Most, if not all,
of the Erp proteins are dispensable for growth of B. burgdorferi in culture, since a high-passage-number clone of B31
contains only cp32-1, cp32-3, and cp32-4, with a mutated erpB gene (11, 43). The truncated
erpB1 allele found in the high-passage-number bacteria
(43) also demonstrates that these bacteria can acquire small
mutations during cultivation in addition to the previously described
loss of plasmids (3, 9, 10, 33, 36, 47), any of which may
contribute to the concurrent loss of infectivity.
The ErpA/I and ErpB2/J proteins elicited a strong immune response in
animals infected with B31. The ErpA/I and ErpC proteins were also
recognized as antigens by sera from 10 of 10 Lyme disease patients from
Long Island, while 8 patients' sera also recognized the ErpB2/J
protein. These data suggest that structural features of at least some
of the B31 Erp proteins may be conserved among different B. burgdorferi bacteria and may be involved in essential functions.
Epitope conservation also suggests that some B31 Erp proteins could
serve as useful Lyme disease diagnostic antigens or components of a
protective vaccine. Analysis of sera from Lyme disease patients from
other geographic locations will indicate whether the production of
antigens similar to the B31 Erp proteins is common in other infectious
B. burgdorferi bacteria.
 |
ACKNOWLEDGMENTS |
We thank Martine Bos, Alan MacDonald, and Erol Fikrig for
providing sera, Kit Tilly, Joseph Hinnebusch, Stephen Porcella, and
Abdallah Elias for constructive comments on the manuscript, Gary
Hettrick and Robert Evans for artwork, and Kelly Matteson and Carole
Smaus for secretarial assistance.
 |
FOOTNOTES |
*
Corresponding author. Present address: Department of
Microbiology and Immunology, MS 415 UKMC, University of Kentucky
College of Medicine, Lexington, KY 40536. Phone: (606) 323-8967. Fax: (606) 257-8994. E-mail: lkspic00{at}pop.uky.edu.
Editor: J. G. Cannon
 |
REFERENCES |
| 1.
|
Akins, D. R.,
S. F. Porcella,
T. G. Popova,
D. Shevchenko,
S. I. Baker,
M. Li,
M. V. Norgard, and J. D. Radolf.
1995.
Evidence for in vivo but not in vitro expression of a Borrelia burgdorferi outer surface protein F (OspF) homologue.
Mol. Microbiol.
18:507-520[Medline].
|
| 2.
|
Amouriaux, P.,
M. Assous,
D. Margarita,
G. Baranton, and I. Saint Girons.
1993.
Polymerase chain reaction with the 30-kb circular plasmid of Borrelia burgdorferi B31 as a target for detection of the Lyme borreliosis agents in cerebrospinal fluid.
Res. Microbiol.
144:211-219[Medline].
|
| 3.
|
Barbour, A. G.
1988.
Plasmid analysis of Borrelia burgdorferi, the Lyme disease agent.
J. Clin. Microbiol.
26:475-478[Abstract/Free Full Text].
|
| 4.
|
Barbour, A. G.,
S. L. Tessier, and H. G. Stoenner.
1982.
Variable major proteins of Borrelia hermsii.
J. Exp. Med.
156:1312-1324[Abstract/Free Full Text].
|
| 5.
|
Benach, J. L.,
J. L. Coleman,
R. A. Skinner, and E. M. Bosler.
1987.
Adult Ixodes dammini on rabbits: a hypothesis for the development and transmission of Borrelia burgdorferi.
J. Infect. Dis.
155:1300-1306[Medline].
|
| 6.
|
Bölin, I.,
D. A. Portnoy, and H. Wolf-Watz.
1985.
Expression of the temperature-inducible outer membrane proteins of yersiniae.
Infect. Immun.
48:234-240[Abstract/Free Full Text].
|
| 7.
|
Bono, J. L.,
K. Tilly,
B. Stevenson,
D. Hogan, and P. Rosa.
1998.
Oligopeptide permease in Borrelia burgdorferi: putative peptide-binding components encoded by both chromosomal and plasmid loci.
Microbiology
144:1033-1044[Abstract/Free Full Text].
|
| 8.
|
Burgdorfer, W.,
A. G. Barbour,
S. F. Hayes,
J. L. Benach,
E. Grunwaldt, and J. P. Davis.
1982.
Lyme disease a tick-borne spirochetosis?
Science
216:1317-1319[Abstract/Free Full Text].
|
| 9.
|
Busch, U.,
G. Will,
C. Hizo-Teufel,
B. Wilske, and V. Preac-Mursic.
1997.
Long term in vitro cultivation of Borrelia burgdorferi sensu lato strains: influence on plasmid patterns, genome stability and expression of proteins.
Res. Microbiol.
148:109-118[Medline].
|
| 10.
|
Carroll, J. A., and F. C. Gherardini.
1996.
Membrane protein variations associated with in vitro passage of Borrelia burgdorferi.
Infect. Immun.
64:392-398[Abstract].
|
| 11.
|
Casjens, S.,
R. van Vugt,
K. Tilly,
P. A. Rosa, and B. Stevenson.
1997.
Homology throughout the multiple 32-kilobase circular plasmids present in Lyme disease spirochetes.
J. Bacteriol.
179:217-227[Abstract/Free Full Text].
|
| 12.
|
Coleman, J. L.,
J. A. Gebbia,
J. Piesman,
J. L. Degen,
T. H. Bugge, and J. L. Benach.
1997.
Plasminogen is required for efficient dissemination of B. burgdorferi in ticks and for enhancement of spirochetemia in mice.
Cell
89:1111-1119[Medline].
|
| 13.
|
Das, S.,
S. W. Barthold,
S. Stocker Giles,
R. R. Montgomery,
S. R. Telford, and E. Fikrig.
1997.
Temporal pattern of Borrelia burgdorferi p21 expression in ticks and the mammalian host.
J. Clin. Invest.
99:987-995[Medline].
|
| 14.
|
de Silva, A. M., and E. Fikrig.
1995.
Growth and migration of Borrelia burgdorferi in Ixodes ticks during blood feeding.
Am. J. Trop. Med. Hyg.
53:397-404.
|
| 15.
|
de Silva, A. M.,
S. R. Telford III,
L. R. Brunet,
S. W. Barthold, and E. Fikrig.
1996.
Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine.
J. Exp. Med.
183:271-275[Abstract/Free Full Text].
|
| 16.
|
Fingerle, V.,
U. Hauser,
G. Liegl,
B. Petko,
V. Preac-Mursic, and B. Wilske.
1995.
Expression of outer surface proteins A and C of Borrelia burgdorferi in Ixodes ricinus.
J. Clin. Microbiol.
33:1867-1869[Abstract].
|
| 17.
|
Fraser, C. M.,
S. Casjens,
W. M. Huang,
G. G. Sutton,
R. Clayton,
R. Lathigra,
O. White,
K. A. Ketchum,
R. Dodson,
E. K. Hickey,
M. Gwinn,
B. Dougherty,
J.-F. Tomb,
R. D. Fleischmann,
D. Richardson,
J. Peterson,
A. R. Kerlavage,
J. Quackenbush,
S. Salzberg,
M. Hanson,
R. van Vugt,
N. Palmer,
M. D. Adams,
J. Gocayne,
J. Weidmann,
T. Utterback,
L. Watthey,
L. McDonald,
P. Artiach,
C. Bowman,
S. Garland,
C. Fujii,
M. D. Cotton,
K. Horst,
K. Roberts,
B. Hatch,
H. O. Smith, and J. C. Venter.
1997.
Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi.
Nature
390:580-586[Medline].
|
| 18.
|
Fuchs, R.,
S. Jauris,
F. Lottspeich,
V. Preac-Mursic,
B. Wilske, and E. Soutschek.
1992.
Molecular analysis and expression of a Borrelia burgdorferi gene encoding a 22kDa protein (pC) in Escherichia coli.
Mol. Microbiol.
6:503-509[Medline].
|
| 19.
|
Gern, L.,
Z. Zhu, and A. Aeschlimann.
1990.
Development of Borrelia burgdorferi in Ixodes ricinus females during blood feeding.
Ann. Parasitol. Hum. Comp.
65:89-93.
|
| 20.
|
Hinnebusch, B. J.,
R. D. Perry, and T. G. Schwan.
1996.
Role of the Yersinia pestis hemin storage (hms) locus in the transmission of plague by fleas.
Science
273:367-370[Abstract].
|
| 21.
|
King, G. J., and J. Swanson.
1978.
Studies on gonococcus infection. XV. Identification of surface proteins of Neisseria gonorrhoeae correlated with leukocyte association.
Infect. Immun.
21:575-584[Abstract/Free Full Text].
|
| 22.
|
Kurtti, T. J.,
U. G. Munderloh,
R. C. Johnson, and G. G. Ahlstrand.
1987.
Colony formation and morphology in Borrelia burgdorferi.
J. Clin. Microbiol.
25:2054-2058[Abstract/Free Full Text].
|
| 23.
|
Lam, T. T.,
T.-P. K. Nguyen,
R. R. Montgomery,
F. S. Kantor,
E. Fikrig, and R. A. Flavell.
1994.
Outer surface proteins E and F of Borrelia burgdorferi, the agent of Lyme disease.
Infect. Immun.
62:290-298[Abstract/Free Full Text].
|
| 24.
|
Maniatis, T.,
E. F. Fritsch, and J. Sambrook.
1982.
In
Molecular cloning: a laboratory manual.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 25.
|
Marconi, R. T.,
S. Y. Sung,
C. A. Norton Hughes, and J. A. Carlyon.
1996.
Molecular and evolutionary analyses of a variable series of genes in Borrelia burgdorferi that are related to ospE and ospF, constitute a gene family, and share a common upstream homology box.
J. Bacteriol.
178:5615-5626[Abstract/Free Full Text].
|
| 26.
|
Miller, J. F.,
J. J. Mekalanos, and S. Falkow.
1989.
Coordinate regulation and sensory transduction in the control of bacterial virulence.
Science
243:916-922[Abstract/Free Full Text].
|
| 27.
|
Nguyen, T.-P. K.,
T. T. Lam,
S. W. Barthold,
S. R. Telford III,
R. A. Flavell, and E. Fikrig.
1994.
Partial destruction of Borrelia burgdorferi within ticks that engorged on OspE- or OspF-immunized mice.
Infect. Immun.
62:2079-2084[Abstract/Free Full Text].
|
| 28.
|
Piesman, J.,
J. R. Oliver, and R. J. Sinsky.
1990.
Growth kinetics of the Lyme disease spirochete (Borrelia burgdorferi) in vector ticks (Ixodes dammini).
Am. J. Trop. Med. Hyg.
42:352-357.
|
| 29.
|
Porcella, S. F.,
T. G. Popova,
D. R. Akins,
M. Li,
J. D. Radolf, and M. V. Norgard.
1996.
Borrelia burgdorferi supercoiled plasmids encode multicopy tandem open reading frames and a lipoprotein gene family.
J. Bacteriol.
178:3293-3307[Abstract/Free Full Text].
|
| 30.
|
Ribeiro, J. M. C.,
T. N. Mather,
J. Piesman, and A. Spielman.
1987.
Dissemination and salivary delivery of Lyme disease spirochetes in vector ticks (Acari: Ixodidae).
J. Med. Entomol.
24:201-205[Medline].
|
| 31.
|
Rosa, P.,
D. S. Samuels,
D. Hogan,
B. Stevenson,
S. Casjens, and K. Tilly.
1996.
Directed insertion of a selectable marker into a circular plasmid of Borrelia burgdorferi.
J. Bacteriol.
178:5946-5953[Abstract/Free Full Text].
|
| 32.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
In
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 33.
|
Schwan, T. G.,
W. Burgdorfer, and C. F. Garon.
1988.
Changes in infectivity and plasmid profile of the Lyme disease spirochete, Borrelia burgdorferi, as a result of in vitro cultivation.
Infect. Immun.
56:1831-1836[Abstract/Free Full Text].
|
| 34.
|
Schwan, T. G.,
J. Piesman,
W. T. Golde,
M. C. Dolan, and P. A. Rosa.
1995.
Induction of an outer surface protein on Borrelia burgdorferi during tick feeding.
Proc. Natl. Acad. Sci. USA
92:2909-2913[Abstract/Free Full Text].
|
| 35.
|
Simpson, W. J.,
W. Burgdorfer,
M. E. Schrumpf,
R. H. Karstens, and T. G. Schwan.
1991.
Antibody to a 39-kilodalton Borrelia burgdorferi antigen (P39) as a marker for infection in experimentally and naturally inoculated animals.
J. Clin. Microbiol.
29:236-243[Abstract/Free Full Text].
|
| 36.
|
Simpson, W. J.,
C. F. Garon, and T. G. Schwan.
1990.
Analysis of supercoiled circular plasmids in infectious and non-infectious Borrelia burgdorferi.
Microb. Pathog.
8:109-118[Medline].
|
| 37.
|
Simpson, W. J.,
M. E. Schrumpf, and T. G. Schwan.
1990.
Reactivity of human Lyme borreliosis sera with a 39-kilodalton antigen specific to Borrelia burgdorferi.
J. Clin. Microbiol.
28:1329-1337[Abstract/Free Full Text].
|
| 38.
|
Spencer, R. R., and R. R. Parker.
1923.
Rocky mountain spotted fever: infectivity of fasting and recently fed ticks.
Public Health Rep.
38:333-339.
|
| 39.
|
Spencer, R. R., and R. R. Parker.
1924.
Rocky mountain spotted fever: experimental studies on tick virus.
Public Health Rep.
39:3027-3040.
|
| 40.
| Stevenson, B., S. Casjens, and P. Rosa.
Evidence of past recombination events among the genes encoding the Erp
antigens of Borrelia burgdorferi. Microbiology, in press.
|
| 41.
|
Stevenson, B.,
S. Casjens,
R. van Vugt,
S. F. Porcella,
K. Tilly,
J. L. Bono, and P. Rosa.
1997.
Characterization of cp18, a naturally truncated member of the cp32 family of Borrelia burgdorferi plasmids.
J. Bacteriol.
179:4285-4291[Abstract/Free Full Text].
|
| 42.
|
Stevenson, B.,
T. G. Schwan, and P. A. Rosa.
1995.
Temperature-related differential expression of antigens in the Lyme disease spirochete, Borrelia burgdorferi.
Infect. Immun.
63:4535-4539[Abstract].
|
| 43.
|
Stevenson, B.,
K. Tilly, and P. A. Rosa.
1996.
A family of genes located on four separate 32-kilobase circular plasmids in Borrelia burgdorferi B31.
J. Bacteriol.
178:3508-3516[Abstract/Free Full Text].
|
| 44.
|
Suk, K.,
S. Das,
W. Sun,
B. Jwang,
S. W. Barthold,
R. A. Flavell, and E. Fikrig.
1995.
Borrelia burgdorferi genes selectively expressed in the infected host.
Proc. Natl. Acad. Sci. USA
92:4269-4273[Abstract/Free Full Text].
|
| 45.
|
Tilly, K.,
S. Casjens,
B. Stevenson,
J. L. Bono,
D. S. Samuels,
D. Hogan, and P. Rosa.
1997.
The Borrelia burgdorferi circular plasmid cp26: conservation of plasmid structure and targeted inactivation of the ospC gene.
Mol. Microbiol.
25:361-373[Medline].
|
| 46.
|
Wallich, R.,
C. Brenner,
M. D. Kramer, and M. M. Simon.
1995.
Molecular cloning and immunological characterization of a novel linear-plasmid-encoded gene, pG, of Borrelia burgdorferi expressed only in vivo.
Infect. Immun.
63:3327-3335[Abstract].
|
| 47.
|
Xu, Y.,
C. Kodner,
L. Coleman, and R. C. Johnson.
1996.
Correlation of plasmids with infectivity of Borrelia burgdorferi sensu stricto type strain B31.
Infect. Immun.
64:3870-3876[Abstract].
|
| 48.
|
Zückert, W. R.,
E. Filipuzzi-Jenny,
J. Meister-Turner,
M. Stålhammar-Carlemalm, and J. Meyer.
1994.
Repeated DNA sequences on circular and linear plasmids of Borrelia burgdorferi sensu lato, p. 253-260.
In
J. S. Axford, and D. H. E. Rees (ed.), Lyme borreliosis. Plenum Press, New York, N.Y.
|
| 49.
|
Zückert, W. R., and J. Meyer.
1996.
Circular and linear plasmids of Lyme disease spirochetes have extensive homology: characterization of a repeated DNA element.
J. Bacteriol.
178:2287-2298[Abstract/Free Full Text].
|
| 50.
|
Zung, J. L.,
S. Lewengrub,
M. A. Rudzinska,
A. Spielman,
S. R. Telford, and J. Piesman.
1989.
Fine structural evidence for the penetration of the Lyme disease spirochete Borrelia burgdorferi through the gut and salivary tissues of Ixodes dammini.
Can. J. Zool.
67:1737-1748.
|
Infect Immun, June 1998, p. 2648-2654, Vol. 66, No. 6
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Brissette, C. A., Bykowski, T., Cooley, A. E., Bowman, A., Stevenson, B.
(2009). Borrelia burgdorferi RevA Antigen Binds Host Fibronectin. Infect. Immun.
77: 2802-2812
[Abstract]
[Full Text]
-
Mulay, V. B., Caimano, M. J., Iyer, R., Dunham-Ems, S., Liveris, D., Petzke, M. M., Schwartz, I., Radolf, J. D.
(2009). Borrelia burgdorferi bba74 Is Expressed Exclusively during Tick Feeding and Is Regulated by Both Arthropod- and Mammalian Host-Specific Signals. J. Bacteriol.
191: 2783-2794
[Abstract]
[Full Text]
-
Brissette, C. A., Verma, A., Bowman, A., Cooley, A. E., Stevenson, B.
(2009). The Borrelia burgdorferi outer-surface protein ErpX binds mammalian laminin. Microbiology
155: 863-872
[Abstract]
[Full Text]
-
Brissette, C. A., Haupt, K., Barthel, D., Cooley, A. E., Bowman, A., Skerka, C., Wallich, R., Zipfel, P. F., Kraiczy, P., Stevenson, B.
(2009). Borrelia burgdorferi Infection-Associated Surface Proteins ErpP, ErpA, and ErpC Bind Human Plasminogen. Infect. Immun.
77: 300-306
[Abstract]
[Full Text]
-
Maruskova, M., Seshu, J.
(2008). Deletion of BBA64, BBA65, and BBA66 Loci Does Not Alter the Infectivity of Borrelia burgdorferi in the Murine Model of Lyme Disease. Infect. Immun.
76: 5274-5284
[Abstract]
[Full Text]
-
Barbour, A. G., Jasinskas, A., Kayala, M. A., Davies, D. H., Steere, A. C., Baldi, P., Felgner, P. L.
(2008). A Genome-Wide Proteome Array Reveals a Limited Set of Immunogens in Natural Infections of Humans and White-Footed Mice with Borrelia burgdorferi. Infect. Immun.
76: 3374-3389
[Abstract]
[Full Text]
-
Kraiczy, P., Seling, A., Brissette, C. A., Rossmann, E., Hunfeld, K.-P., Bykowski, T., Burns, L. H., Troese, M. J., Cooley, A. E., Miller, J. C., Brade, V., Wallich, R., Casjens, S., Stevenson, B.
(2008). Borrelia burgdorferi Complement Regulator-Acquiring Surface Protein 2 (CspZ) as a Serological Marker of Human Lyme Disease. CVI
15: 484-491
[Abstract]
[Full Text]
-
Gilmore, R. D. Jr., Howison, R. R., Schmit, V. L., Nowalk, A. J., Clifton, D. R., Nolder, C., Hughes, J. L., Carroll, J. A.
(2007). Temporal Expression Analysis of the Borrelia burgdorferi Paralogous Gene Family 54 Genes BBA64, BBA65, and BBA66 during Persistent Infection in Mice. Infect. Immun.
75: 2753-2764
[Abstract]
[Full Text]
-
Nowalk, A. J., Gilmore, R. D. Jr, Carroll, J. A.
(2006). Serologic Proteome Analysis of Borrelia burgdorferi Membrane-Associated Proteins. Infect. Immun.
74: 3864-3873
[Abstract]
[Full Text]
-
Bykowski, T., Babb, K., von Lackum, K., Riley, S. P., Norris, S. J., Stevenson, B.
(2006). Transcriptional Regulation of the Borrelia burgdorferi Antigenically Variable VlsE Surface Protein. J. Bacteriol.
188: 4879-4889
[Abstract]
[Full Text]
-
Babb, K., Bykowski, T., Riley, S. P., Miller, M. C., DeMoll, E., Stevenson, B.
(2006). Borrelia burgdorferi EbfC, a Novel, Chromosomally Encoded Protein, Binds Specific DNA Sequences Adjacent to erp Loci on the Spirochete's Resident cp32 Prophages.. J. Bacteriol.
188: 4331-4339
[Abstract]
[Full Text]
-
Hovis, K. M., Tran, E., Sundy, C. M., Buckles, E., McDowell, J. V., Marconi, R. T.
(2006). Selective Binding of Borrelia burgdorferi OspE Paralogs to Factor H and Serum Proteins from Diverse Animals: Possible Expansion of the Role of OspE in Lyme Disease Pathogenesis. Infect. Immun.
74: 1967-1972
[Abstract]
[Full Text]
-
von Lackum, K., Miller, J. C., Bykowski, T., Riley, S. P., Woodman, M. E., Brade, V., Kraiczy, P., Stevenson, B., Wallich, R.
(2005). Borrelia burgdorferi Regulates Expression of Complement Regulator-Acquiring Surface Protein 1 during the Mammal-Tick Infection Cycle. Infect. Immun.
73: 7398-7405
[Abstract]
[Full Text]
-
Brooks, C. S., Vuppala, S. R., Jett, A. M., Alitalo, A., Meri, S., Akins, D. R.
(2005). Complement Regulator-Acquiring Surface Protein 1 Imparts Resistance to Human Serum in Borrelia burgdorferi. J. Immunol.
175: 3299-3308
[Abstract]
[Full Text]
-
Caimano, M. J., Eggers, C. H., Hazlett, K. R. O., Radolf, J. D.
(2004). RpoS Is Not Central to the General Stress Response in Borrelia burgdorferi but Does Control Expression of One or More Essential Virulence Determinants. Infect. Immun.
72: 6433-6445
[Abstract]
[Full Text]
-
Eggers, C. H., Caimano, M. J., Radolf, J. D.
(2004). Analysis of Promoter Elements Involved in the Transcriptional Initiation of RpoS-Dependent Borrelia burgdorferi Genes. J. Bacteriol.
186: 7390-7402
[Abstract]
[Full Text]
-
Babb, K., McAlister, J. D., Miller, J. C., Stevenson, B.
(2004). Molecular Characterization of Borrelia burgdorferi erp Promoter/Operator Elements. J. Bacteriol.
186: 2745-2756
[Abstract]
[Full Text]
-
Pinne, M., Ostberg, Y., Comstedt, P., Bergstrom, S.
(2004). Molecular analysis of the channel-forming protein P13 and its paralogue family 48 from different Lyme disease Borrelia species. Microbiology
150: 549-559
[Abstract]
[Full Text]
-
Kraiczy, P., Hellwage, J., Skerka, C., Becker, H., Kirschfink, M., Simon, M. M., Brade, V., Zipfel, P. F., Wallich, R.
(2004). Complement Resistance of Borrelia burgdorferi Correlates with the Expression of BbCRASP-1, a Novel Linear Plasmid-encoded Surface Protein That Interacts with Human Factor H and FHL-1 and Is Unrelated to Erp Proteins. J. Biol. Chem.
279: 2421-2429
[Abstract]
[Full Text]
-
Miller, J. C., von Lackum, K., Babb, K., McAlister, J. D., Stevenson, B.
(2003). Temporal Analysis of Borrelia burgdorferi Erp Protein Expression throughout the Mammal-Tick Infectious Cycle. Infect. Immun.
71: 6943-6952
[Abstract]
[Full Text]
-
Hodzic, E., Feng, S., Freet, K. J., Barthold, S. W.
(2003). Borrelia burgdorferi Population Dynamics and Prototype Gene Expression during Infection of Immunocompetent and Immunodeficient Mice. Infect. Immun.
71: 5042-5055
[Abstract]
[Full Text]
-
Iyer, R., Kalu, O., Purser, J., Norris, S., Stevenson, B., Schwartz, I.
(2003). Linear and Circular Plasmid Content in Borrelia burgdorferi Clinical Isolates. Infect. Immun.
71: 3699-3706
[Abstract]
[Full Text]
-
McDowell, J. V., Wolfgang, J., Tran, E., Metts, M. S., Hamilton, D., Marconi, R. T.
(2003). Comprehensive Analysis of the Factor H Binding Capabilities of Borrelia Species Associated with Lyme Disease: Delineation of Two Distinct Classes of Factor H Binding Proteins. Infect. Immun.
71: 3597-3602
[Abstract]
[Full Text]
-
Miller, J. C., Stevenson, B.
(2003). Immunological and genetic characterization of Borrelia burgdorferi BapA and EppA proteins. Microbiology
149: 1113-1125
[Abstract]
[Full Text]
-
Ojaimi, C., Brooks, C., Casjens, S., Rosa, P., Elias, A., Barbour, A., Jasinskas, A., Benach, J., Katona, L., Radolf, J., Caimano, M., Skare, J., Swingle, K., Akins, D., Schwartz, I.
(2003). Profiling of Temperature-Induced Changes in Borrelia burgdorferi Gene Expression by Using Whole Genome Arrays. Infect. Immun.
71: 1689-1705
[Abstract]
[Full Text]
-
Hefty, P. S., Brooks, C. S., Jett, A. M., White, G. L., Wikel, S. K., Kennedy, R. C., Akins, D. R.
(2002). OspE-Related, OspF-Related, and Elp Lipoproteins Are Immunogenic in Baboons Experimentally Infected with Borrelia burgdorferi and in Human Lyme Disease Patients. J. Clin. Microbiol.
40: 4256-4265
[Abstract]
[Full Text]
-
Stevenson, B.
(2002). Borrelia burgdorferi erp (ospE-Related) Gene Sequences Remain Stable during Mammalian Infection. Infect. Immun.
70: 5307-5311
[Abstract]
[Full Text]
-
El-Hage, N., Stevenson, B.
(2002). Simultaneous Coexpression of Borrelia burgdorferi Erp Proteins Occurs through a Specific, erp Locus-Directed Regulatory Mechanism. J. Bacteriol.
184: 4536-4543
[Abstract]
[Full Text]
-
Stevenson, B., Babb, K.
(2002). LuxS-Mediated Quorum Sensing in Borrelia burgdorferi, the Lyme Disease Spirochete. Infect. Immun.
70: 4099-4105
[Abstract]
[Full Text]
-
Hodzic, E., Feng, S., Freet, K. J., Borjesson, D. L., Barthold, S. W.
(2002). Borrelia burgdorferi Population Kinetics and Selected Gene Expression at the Host-Vector Interface. Infect. Immun.
70: 3382-3388
[Abstract]
[Full Text]
-
Hefty, P. S., Jolliff, S. E., Caimano, M. J., Wikel, S. K., Akins, D. R.
(2002). Changes in Temporal and Spatial Patterns of Outer Surface Lipoprotein Expression Generate Population Heterogeneity and Antigenic Diversity in the Lyme Disease Spirochete, Borrelia burgdorferi. Infect. Immun.
70: 3468-3478
[Abstract]
[Full Text]
-
Elias, A. F., Stewart, P. E., Grimm, D., Caimano, M. J., Eggers, C. H., Tilly, K., Bono, J. L., Akins, D. R., Radolf, J. D., Schwan, T. G., Rosa, P.
(2002). Clonal Polymorphism of Borrelia burgdorferi Strain B31 MI: Implications for Mutagenesis in an Infectious Strain Background. Infect. Immun.
70: 2139-2150
[Abstract]
[Full Text]
-
Heikkila, T., Seppala, I., Saxen, H., Panelius, J., Peltomaa, M., Julin, T., Carlsson, S.-A., Lahdenne, P.
(2002). Recombinant BBK32 Protein in Serodiagnosis of Early and Late Lyme Borreliosis. J. Clin. Microbiol.
40: 1174-1180
[Abstract]
[Full Text]
-
Stevenson, B., El-Hage, N., Hines, M. A., Miller, J. C., Babb, K.
(2002). Differential Binding of Host Complement Inhibitor Factor H by Borrelia burgdorferi Erp Surface Proteins: a Possible Mechanism Underlying the Expansive Host Range of Lyme Disease Spirochetes. Infect. Immun.
70: 491-497
[Abstract]
[Full Text]
-
Kraiczy, P., Skerka, C., Brade, V., Zipfel, P. F.
(2001). Further Characterization of Complement Regulator-Acquiring Surface Proteins of Borrelia burgdorferi. Infect. Immun.
69: 7800-7809
[Abstract]
[Full Text]
-
Anguita, J., Thomas, V., Samanta, S., Persinski, R., Hernanz, C., Barthold, S. W., Fikrig, E.
(2001). Borrelia burgdorferi-Induced Inflammation Facilitates Spirochete Adaptation and Variable Major Protein-Like Sequence Locus Recombination. J. Immunol.
167: 3383-3390
[Abstract]
[Full Text]
-
Carroll, J. A., El-Hage, N., Miller, J. C., Babb, K., Stevenson, B.
(2001). Borrelia burgdorferi RevA Antigen Is a Surface-Exposed Outer Membrane Protein Whose Expression Is Regulated in Response to Environmental Temperature and pH. Infect. Immun.
69: 5286-5293
[Abstract]
[Full Text]
-
McDowell, J. V., Sung, S. Y., Price, G., Marconi, R. T.
(2001). Demonstration of the Genetic Stability and Temporal Expression of Select Members of the Lyme Disease Spirochete OspF Protein Family during Infection in Mice. Infect. Immun.
69: 4831-4838
[Abstract]
[Full Text]
-
Pal, U., Montgomery, R. R., Lusitani, D., Voet, P., Weynants, V., Malawista, S. E., Lobet, Y., Fikrig, E.
(2001). Inhibition of Borrelia burgdorferi-Tick Interactions In Vivo by Outer Surface Protein A Antibody. J. Immunol.
166: 7398-7403
[Abstract]
[Full Text]
-
Hefty, P. S., Jolliff, S. E., Caimano, M. J., Wikel, S. K., Radolf, J. D., Akins, D. R.
(2001). Regulation of OspE-Related, OspF-Related, and Elp Lipoproteins of Borrelia burgdorferi Strain 297 by Mammalian Host-Specific Signals. Infect. Immun.
69: 3618-3627
[Abstract]
[Full Text]
-
McDowell, J. V., Sung, S. Y., Labandeira-Rey, M., Skare, J. T., Marconi, R. T.
(2001). Analysis of Mechanisms Associated with Loss of Infectivity of Clonal Populations of Borrelia burgdorferi B31MI. Infect. Immun.
69: 3670-3677
[Abstract]
[Full Text]
-
Babb, K., El-Hage, N., Miller, J. C., Carroll, J. A., Stevenson, B.
(2001). Distinct Regulatory Pathways Control Expression of Borrelia burgdorferi Infection-Associated OspC and Erp Surface Proteins. Infect. Immun.
69: 4146-4153
[Abstract]
[Full Text]
-
Yang, X., Popova, T. G., Goldberg, M. S., Norgard, M. V.
(2001). Influence of Cultivation Media on Genetic Regulatory Patterns in Borrelia burgdorferi. Infect. Immun.
69: 4159-4163
[Abstract]
[Full Text]
-
Ramamoorthy, R., Scholl-Meeker, D.
(2001). Borrelia burgdorferi Proteins Whose Expression Is Similarly Affected by Culture Temperature and pH. Infect. Immun.
69: 2739-2742
[Abstract]
[Full Text]
-
El-Hage, N., Babb, K., Carroll, J. A., Lindstrom, N., Fischer, E. R., Miller, J. C., Gilmore, R. D. Jr, Mbow, M. L., Stevenson, B.
(2001). Surface exposure and protease insensitivity of Borrelia burgdorferi Erp (OspEF-related) lipoproteins. Microbiology
147: 821-830
[Abstract]
[Full Text]
-
Damman, C. J., Eggers, C. H., Samuels, D. S., Oliver, D. B.
(2000). Characterization of Borrelia burgdorferi BlyA and BlyB Proteins: a Prophage-Encoded Holin-Like System. J. Bacteriol.
182: 6791-6797
[Abstract]
[Full Text]
-
Miller, J. C., Bono, J. L., Babb, K., El-Hage, N., Casjens, S., Stevenson, B.
(2000). A Second Allele of eppA in Borrelia burgdorferi Strain B31 Is Located on the Previously Undetected Circular Plasmid cp9-2. J. Bacteriol.
182: 6254-6258
[Abstract]
[Full Text]
-
Porcella, S. F., Fitzpatrick, C. A., Bono, J. L.
(2000). Expression and Immunological Analysis of the Plasmid-Borne mlp Genes of Borrelia burgdorferi Strain B31. Infect. Immun.
68: 4992-5001
[Abstract]
[Full Text]
-
Stevenson, B., Porcella, S. F., Oie, K. L., Fitzpatrick, C. A., Raffel, S. J., Lubke, L., Schrumpf, M. E., Schwan, T. G.
(2000). The Relapsing Fever Spirochete Borrelia hermsii Contains Multiple, Antigen-Encoding Circular Plasmids That Are Homologous to the cp32 Plasmids of Lyme Disease Spirochetes. Infect. Immun.
68: 3900-3908
[Abstract]
[Full Text]
-
Feng, S., Hodzic, E., Barthold, S. W.
(2000). Lyme Arthritis Resolution with Antiserum to a 37-Kilodalton Borrelia burgdorferi Protein. Infect. Immun.
68: 4169-4173
[Abstract]
[Full Text]
-
Haake, D. A.
(2000). Spirochaetal lipoproteins and pathogenesis. Microbiology
146: 1491-1504
[Full Text]
-
Fikrig, E., Feng, W., Barthold, S. W., Telford, S. R. III, Flavell, R. A.
(2000). Arthropod- and Host-Specific Borrelia burgdorferi bbk32 Expression and the Inhibition of Spirochete Transmission. J. Immunol.
164: 5344-5351
[Abstract]
[Full Text]
-
Bono, J. L., Elias, A. F., Kupko, J. J. III, Stevenson, B., Tilly, K., Rosa, P.
(2000). Efficient Targeted Mutagenesis in Borrelia burgdorferi. J. Bacteriol.
182: 2445-2452
[Abstract]
[Full Text]
-
Palmer, N., Fraser, C., Casjens, S.
(2000). Distribution of Twelve Linear Extrachromosomal DNAs in Natural Isolates of Lyme Disease Spirochetes. J. Bacteriol.
182: 2476-2480
[Abstract]
[Full Text]
-
Gorbacheva, V. Y., Godfrey, H. P., Cabello, F. C.
(2000). Analysis of the bmp Gene Family in Borrelia burgdorferi Sensu Lato. J. Bacteriol.
182: 2037-2042
[Abstract]
[Full Text]
-
Miller, J. C., El-Hage, N., Babb, K., Stevenson, B.
(2000). Borrelia burgdorferi B31 Erp Proteins That Are Dominant Immunoblot Antigens of Animals Infected with Isolate B31 Are Recognized by Only a Subset of Human Lyme Disease Patient Sera. J. Clin. Microbiol.
38: 1569-1574
[Abstract]
[Full Text]
-
Anguita, J., Samanta, S., Revilla, B., Suk, K., Das, S., Barthold, S. W., Fikrig, E.
(2000). Borrelia burgdorferi Gene Expression In Vivo and Spirochete Pathogenicity. Infect. Immun.
68: 1222-1230
[Abstract]
[Full Text]
-
Sung, S. Y., McDowell, J. V., Carlyon, J. A., Marconi, R. T.
(2000). Mutation and Recombination in the Upstream Homology Box-Flanked ospE-Related Genes of the Lyme Disease Spirochetes Result in the Development of New Antigenic Variants during Infection. Infect. Immun.
68: 1319-1327
[Abstract]
[Full Text]
-
Caimano, M. J., Yang, X., Popova, T. G., Clawson, M. L., Akins, D. R., Norgard, M. V., Radolf, J. D.
(2000). Molecular and Evolutionary Characterization of the cp32/18 Family of Supercoiled Plasmids in Borrelia burgdorferi 297. Infect. Immun.
68: 1574-1586
[Abstract]
[Full Text]
-
Zuckert, W. R., Barbour, A. G.
(2000). Stability of Borrelia burgdorferi bdr Loci In Vitro and In Vivo. Infect. Immun.
68: 1727-1730
[Abstract]
[Full Text]
-
Indest, K. J., Philipp, M. T.
(2000). DNA-Binding Proteins Possibly Involved in Regulation of the Post-Logarithmic-Phase Expression of Lipoprotein P35 in Borrelia burgdorferi. J. Bacteriol.
182: 522-525
[Abstract]
[Full Text]
-
Yang, X., Popova, T. G., Hagman, K. E., Wikel, S. K., Schoeler, G. B., Caimano, M. J., Radolf, J. D., Norgard, M. V.
(1999). Identification, Characterization, and Expression of Three New Members of the Borrelia burgdorferi Mlp (2.9) Lipoprotein Gene Family. Infect. Immun.
67: 6008-6018
[Abstract]
[Full Text]
-
Skare, J. T., Foley, D. M., Hernandez, S. R., Moore, D. C., Blanco, D. R., Miller, J. N., Lovett, M. A.
(1999). Cloning and Molecular Characterization of Plasmid-Encoded Antigens of Borrelia burgdorferi. Infect. Immun.
67: 4407-4417
[Abstract]
[Full Text]
-
Zuckert, W. R., Meyer, J., Barbour, A. G.
(1999). Comparative Analysis and Immunological Characterization of the Borrelia Bdr Protein Family. Infect. Immun.
67: 3257-3266
[Abstract]
[Full Text]
-
Obonyo, M., Munderloh, U. G., Fingerle, V., Wilske, B., Kurtti, T. J.
(1999). Borrelia burgdorferi in Tick Cell Culture Modulates Expression of Outer Surface Proteins A and C in Response to Temperature. J. Clin. Microbiol.
37: 2137-2141
[Abstract]
[Full Text]
-
El Hage, N., Lieto, L. D., Stevenson, B.
(1999). Stability of erp Loci during Borrelia burgdorferi Infection: Recombination Is Not Required for Chronic Infection of Immunocompetent Mice. Infect. Immun.
67: 3146-3150
[Abstract]
[Full Text]
-
Stevenson, B., Bono, J. L., Elias, A., Tilly, K., Rosa, P.
(1998). Transformation of the Lyme Disease Spirochete Borrelia burgdorferi with Heterologous DNA. J. Bacteriol.
180: 4850-4855
[Abstract]
[Full Text]